Login

Company Executives

Management Team

From Forms 3, 4 and 5 filed in the last 18 months
Officer Age In this role Joined 2024 pay Source
Christopher Ryan Cave Barrett
See Remarks
Title from the Form 4 dated Oct 1, 2025
Not stated Not stated Not stated Not reported
Srinivas Rao
See Remarks
Title from the Form 4 dated Aug 13, 2025
Not stated Not stated Not stated $3,462,560

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
6
serving now
Independent
0 of 1
stated in the proxy; 5 not stated
Average tenure
Not stated
from year joined
CEO also chairs the board
No
Christian Angermayer
Director Age On board Independent Committees Other public boards 2024 pay Source
Christian Angermayer
46 Not stated Not independent None stated None stated $2,160,977
Sabrina Martucci Johnson
58 Not stated Not stated
Audit · Chair Nominating · Chair
Dare Bioscience, Inc. $177,026
Amir Kalali, M.D.
59 Not stated Not stated
Audit Nominating Science and Technology
None stated $164,852
Andrea Heslin Smiley
57 Not stated Not stated
Audit Compensation · Chair Nominating
Rockwell Medical, Inc. $176,457
Scott Braunstein, M.D.
61 Not stated Not stated
Audit Science and Technology · Chair
Caribou Biosciences, Inc., Trevena Inc. $249,091
Laurent Fischer, M.D.
61 Not stated Not stated
Compensation Science and Technology
Mirum Pharmaceuticals, Inc. $246,341
Nominated to join at the meeting
Not on the board yet; they join only if elected.

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 21, 2025
Christian Angermayer
non-employee member of our supervisory board
$1,769,137
2024

Stock options granted to Mr. Angermayer as compensation for consulting services under his 2024 Consultancy Agreement.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support